US EditionEXCLUSIVE: Why Tom Cruise Is One of Hollywood's Few A-Listers Refusing to Take Ozempic — As He 'Fights to Work Off Man Boobs the Natural Way'
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.7 Articles
7 Articles
noticiasdealava.eus
Experts in Endocrinology, Nutrition, Diabetes and Cardiovascular Diseases have warned this Friday of the "banalization" of drugs such as ozempic, wegovy or mounjaro, increasingly popular to lose weight for purely aesthetic purposes and whose long-term effects are still unknown.
Semaglutide, such as ozempic, or tirzepatide, such as mounjaro, have shown “extraordinary effects” against obesity, with results of up to 25% of the excess weight lost; however, its growing popularity has led society to think that these are treatments that “come very well for the bikini operation, and that’s not so.” This has been emphasized by doctor José Manuel Cucalón, of the working group on Endocrinology and Nutrition of the Spanish Society…
Semaglutide, the active substance of the medicines that make up the ‘Ozempic family’, has led to a transformation in the approach to type 2 diabetes and obesity. Their clinical efficacy has made them protagonists of a genuine therapeutic revolution, not exempt from controversy because of its use outside the indication and supply problems, among others. Now, with the possible approval of a new use, that revolution could open a new chapter in Euro…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
